Bone Biologics Corp

Bone Biologics Corp (BBLG) shows no cyber incidents or red-flag 8-Ks in our 90-day monitoring window, indicating operational stability on near-term filing metrics. However, low signal in a short window does not eliminate equity risk; the full $49 Report extends analysis to 12 months of filings, quantifies dilution exposure and financing history, and applies AI-driven signals for structural vulnerabilities. The Report contextualizes any capital raises, insider moves, or covenant pressures that may not yet appear as formal red flags. The full $49 Report adds dilution risk scoring, 12-month 8-K forensics, and financing trajectory analysis.